• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经甲床递药 AR-12:一种新型抗真菌药物

Trans-ungual Delivery of AR-12, a Novel Antifungal Drug.

机构信息

The University of Mississippi, School of Pharmacy, University, Mississippi, USA.

Institute for Drug Delivery and Biomedical Research, Bangalore, India.

出版信息

AAPS PharmSciTech. 2017 Oct;18(7):2702-2705. doi: 10.1208/s12249-017-0752-y. Epub 2017 Mar 13.

DOI:10.1208/s12249-017-0752-y
PMID:28289970
Abstract

AR-12 is a novel small molecule with broad spectrum antifungal activity. Recently, AR-12 was found to be highly active against Trichophyton rubrum, one of the predominantly responsible organisms that cause onychomycosis. The primary objective of this project was to investigate the ability of AR-12 to penetrate into and across the human nail plate followed by improving its trans-ungual permeation using different penetration enhancers. TranScreen-N™, a high throughput screening method was utilized to explore the potential nail penetration enhancers to facilitate the drug delivery through the nail. This screen demonstrated that dexpanthenol and PEG 400 were the most efficient enhancers. The in vitro permeation studies were performed across the human cadaver nail plates for 7 days with three AR-12 (5% w/v) formulations containing 10% w/v dexpanthenol (Formulation A), 10% w/v PEG 400 (Formulation B), and a combination of 10% w/v dexpanthenol + 10% w/v PEG 400 (Formulation C). The in vitro studies concluded that dexpanthenol and PEG 400 were able to deliver a significant amount of AR-12 into and across the nail plate that was found to be more than MIC 50 level of the drug.

摘要

AR-12 是一种具有广谱抗真菌活性的新型小分子药物。最近,研究发现 AR-12 对引起甲真菌病的主要病原体之一红色毛癣菌具有高度活性。该项目的主要目的是研究 AR-12 穿透并穿过人指甲板的能力,然后使用不同的渗透增强剂来提高其跨甲渗透性。TranScreen-N™是一种高通量筛选方法,用于探索潜在的指甲渗透增强剂,以促进药物通过指甲的输送。该筛选表明,泛醇和聚乙二醇 400 是最有效的增强剂。将三种含有 5% w/v AR-12 的制剂(分别含有 10% w/v 泛醇的制剂 A、10% w/v 聚乙二醇 400 的制剂 B 以及 10% w/v 泛醇+10% w/v 聚乙二醇 400 的制剂 C)进行了为期 7 天的体外渗透研究,研究了它们穿过人尸体指甲板的渗透情况。体外研究表明,泛醇和聚乙二醇 400 能够将大量的 AR-12 递送到指甲板中并穿过指甲板,研究发现药物的浓度超过了 MIC50 水平。

相似文献

1
Trans-ungual Delivery of AR-12, a Novel Antifungal Drug.经甲床递药 AR-12:一种新型抗真菌药物
AAPS PharmSciTech. 2017 Oct;18(7):2702-2705. doi: 10.1208/s12249-017-0752-y. Epub 2017 Mar 13.
2
TranScreen-N: Method for rapid screening of trans-ungual drug delivery enhancers.TranScreen-N:一种快速筛选经皮药物传递增强剂的方法。
J Pharm Sci. 2009 Nov;98(11):4264-71. doi: 10.1002/jps.21743.
3
Effect of polyethylene glycols on the trans-ungual delivery of terbinafine.聚乙二醇对特比萘芬经皮给药的影响。
Curr Drug Deliv. 2010 Dec;7(5):407-14. doi: 10.2174/156720110793566308.
4
Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis.指甲和甲下离子电渗疗法治疗甲真菌病的特比萘芬。
J Pharm Sci. 2009 Nov;98(11):4130-40. doi: 10.1002/jps.21711.
5
Permeation studies of novel terbinafine formulations containing hydrophobins through human nails in vitro.新型含亲脂蛋白的特比萘芬制剂经体外人指甲渗透研究。
Int J Pharm. 2010 Sep 15;397(1-2):67-76. doi: 10.1016/j.ijpharm.2010.06.051. Epub 2010 Jul 8.
6
Characterization of Antifungal Activity and Nail Penetration of ME1111, a New Antifungal Agent for Topical Treatment of Onychomycosis.新型抗真菌药物ME1111用于甲癣局部治疗的抗真菌活性及指甲穿透性特征
Antimicrob Agents Chemother. 2015 Dec 7;60(2):1035-9. doi: 10.1128/AAC.01739-15. Print 2016 Feb.
7
Ciclopirox delivery into the human nail plate using novel lipid diffusion enhancers.新型脂质扩散增强剂经皮递送至人指甲板的环吡酮胺。
Drug Dev Ind Pharm. 2014 Jun;40(6):838-44. doi: 10.3109/03639045.2013.788016. Epub 2013 Apr 19.
8
Trans-ungual iontophoretic delivery of terbinafine.特比萘芬的经甲离子电渗疗法给药
J Pharm Sci. 2009 May;98(5):1788-96. doi: 10.1002/jps.21555.
9
Novel nail penetration enhancer containing vesicles "nPEVs" for treatment of onychomycosis.用于治疗甲癣的新型含囊泡指甲渗透促进剂“nPEVs”
Drug Deliv. 2016 Oct;23(8):2813-2819. doi: 10.3109/10717544.2015.1099059. Epub 2015 Oct 8.
10
Terbinafine Hydrochloride Trans-ungual Delivery via Nanovesicular Systems: In Vitro Characterization and Ex Vivo Evaluation.通过纳米囊泡系统实现盐酸特比萘芬的经甲递送:体外表征与离体评估
AAPS PharmSciTech. 2017 Feb;18(2):551-562. doi: 10.1208/s12249-016-0528-9. Epub 2016 May 2.

引用本文的文献

1
Dermatophytosis in context of Trichophyton rubrum: host defense mechanisms, virulence factors, and treatment innovations.红色毛癣菌所致皮肤癣菌病:宿主防御机制、毒力因子及治疗新进展
Mol Biol Rep. 2025 Jun 24;52(1):634. doi: 10.1007/s11033-025-10744-4.
2
Newer Therapies in Dermatophytosis.皮肤癣菌病的新型疗法
Indian J Dermatol. 2023 Sep-Oct;68(5):515-519. doi: 10.4103/ijd.ijd_829_23.
3
Contemporary Techniques and Potential Transungual Drug Delivery Nanosystems for The Treatment of Onychomycosis.当代技术与经皮给药纳米系统治疗甲真菌病的潜在研究进展。
AAPS PharmSciTech. 2023 Jul 8;24(6):150. doi: 10.1208/s12249-023-02603-x.
4
Design, Development, and Evaluation of Constant Voltage Iontophoresis for the Transungual Delivery of Efinaconazole.用于环吡酮胺经皮给药的恒压离子电渗疗法的设计、开发与评估。
Pharmaceutics. 2023 May 6;15(5):1422. doi: 10.3390/pharmaceutics15051422.
5
Comparative Ungual Drug Uptake Studies: Equine Hoof Membrane vs. Human Nail Plate.比较性蹄部药物吸收研究:马蹄膜与人指甲板的对比
Pharmaceutics. 2022 Nov 22;14(12):2552. doi: 10.3390/pharmaceutics14122552.
6
AR-12 Exhibits Direct and Host-Targeted Antibacterial Activity toward .AR-12 对. 表现出直接的和宿主靶向的抗菌活性。
Antimicrob Agents Chemother. 2020 Jul 22;64(8). doi: 10.1128/AAC.00236-20.
7
Hope on the Horizon: Novel Fungal Treatments in Development.曙光在前:正在研发的新型真菌治疗方法
Open Forum Infect Dis. 2020 Jan 12;7(2):ofaa016. doi: 10.1093/ofid/ofaa016. eCollection 2020 Feb.
8
Preparation and evaluation of a highly skin- and nail-permeable efinaconazole topical formulation for enhanced treatment of onychomycosis.制备并评价一种高透皮和透甲的依非康唑局部用制剂,以增强治疗甲真菌病的效果。
Drug Deliv. 2019 Dec;26(1):1167-1177. doi: 10.1080/10717544.2019.1687612.
9
Dermatophyte Resistance to Antifungal Drugs: Mechanisms and Prospectus.皮肤癣菌对抗真菌药物的耐药性:机制与展望
Front Microbiol. 2018 May 29;9:1108. doi: 10.3389/fmicb.2018.01108. eCollection 2018.
10
Newer Topical Treatments in Skin and Nail Dermatophyte Infections.皮肤和指甲皮肤癣菌感染的新型局部治疗方法。
Indian Dermatol Online J. 2018 May-Jun;9(3):149-158. doi: 10.4103/idoj.IDOJ_281_17.